Liver Disease in Patients After the Fontan Operation

被引:124
|
作者
Pundi, Krishna [1 ]
Pundi, Kavitha N. [2 ]
Kamath, Patrick S. [3 ]
Cetta, Frank [2 ,4 ]
Li, Zhuo [5 ]
Poterucha, Joseph T. [2 ]
Driscoll, David J. [2 ]
Johnson, Jonathan N. [2 ,4 ]
机构
[1] Mayo Clin, Coll Med, Rochester, MN USA
[2] Mayo Clin, Dept Pediat, Div Pediat Cardiol, Rochester, MN USA
[3] Mayo Clin, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN USA
[4] Mayo Clin, Dept Med, Div Cardiovasc Dis, Rochester, MN USA
[5] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2016年 / 117卷 / 03期
关键词
LONG-TERM SURVIVAL; CARDIAC CIRRHOSIS; TRICUSPID ATRESIA; HEART-TRANSPLANT; MORTALITY; PREDICTORS; PATHOLOGY; FIBROSIS;
D O I
10.1016/j.amjcard.2015.11.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We reviewed records of all patients with an initial Fontan operation or revision from 1973 to 2012 at our institution (n = 1,138); 195 patients had postoperative liver data available. Cirrhosis was identified by histopathology or characteristic findings on imaging with an associated diagnosis of cirrhosis by a hepatologist. Of 195 patients with biopsy or imaging, 10-, 20-, and 30 -year freedom from cirrhosis was 99%, 94%, and 57%, respectively. There were 40 of 195 patients (21%) diagnosed with cirrhosis (mean age at Fontan 10.7 +/- 8 years). On multivariate analysis, hypoplastic left heart syndrome was associated with increased risk of cirrhosis (n = 2 of 16, p = 0.0133), whereas preoperative sinus rhythm was protective (p = 0.009). Survival after diagnosis of cirrhosis was 57% and 35%, at 1, and 5 years, respectively. The cause of death was known for 9 patients (5 multiorgan failure, 2 liver failure, and 2 heart failure). In conclusion, there is an incremental occurrence of cirrhosis after the Fontan, which should be considered when designing follow-up protocols for patients after Fontan operation. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:456 / 460
页数:5
相关论文
共 50 条
  • [31] Contraception Practices and Pregnancy Outcome in Patients after Fontan Operation
    Pundi, Kavitha N.
    Pundi, Krishna
    Johnson, Jonathan N.
    Dearani, Joseph A.
    Bonnichsen, Crystal R.
    Phillips, Sabrina D.
    Canobbio, Mary C.
    Driscoll, David J.
    Cetta, Frank
    CONGENITAL HEART DISEASE, 2016, 11 (01) : 63 - 70
  • [32] Plasma volume status in patients after Fontan operation: Prognostic value and the associations with Fontan pathophysiology
    Ohuchi, Hideo
    Sasaki, Osamu
    Hayama, Yosuke
    Miike, Hikari
    Kurosaki, Kenichi
    Shiraishi, Isao
    Nakai, Michikazu
    Yamada, Osamu
    INTERNATIONAL JOURNAL OF CARDIOLOGY CONGENITAL HEART DISEASE, 2021, 5
  • [33] MRI measured liver stiffness does not predict focal liver lesions after the Fontan operation
    Diaz, Eric S.
    Dillman, Jonathan R.
    Veldtman, Gruschen R.
    Trout, Andrew T.
    PEDIATRIC RADIOLOGY, 2019, 49 (01) : 99 - 104
  • [34] Incidence and Expected Probability of Liver Cirrhosis and Hepatocellular Carcinoma After Fontan Operation
    Nii, Masaki
    Inuzuka, Ryo
    Inai, Kei
    Shimada, Eriko
    Shinohara, Tokuko
    Kogiso, Tomomi
    Ono, Hiroshi
    Ootsuki, Shinichi
    Kurita, Yoshihiko
    Takeda, Atsuhito
    Hirono, Keiichi
    Takei, Kota
    Yasukochi, Satoshi
    Yoshikawa, Tadahiro
    Furutani, Yoshiyuki
    Shinozaki, Tomohiro
    Matsuyama, Yutaka
    Senzaki, Hideaki
    Tokushige, Katsutoshi
    Nakanishi, Toshio
    CIRCULATION, 2021, 144 (25) : 2043 - 2045
  • [35] MRI measured liver stiffness does not predict focal liver lesions after the Fontan operation
    Eric S. Diaz
    Jonathan R. Dillman
    Gruschen R. Veldtman
    Andrew T. Trout
    Pediatric Radiology, 2019, 49 : 99 - 104
  • [36] PREDICTORS OF ADVERSE LIVER-RELATED OUTCOMES IN ADULTS AFTER THE FONTAN OPERATION
    Patel, Bhavesh
    Serper, Marina
    Ruckdeschel, Emily
    Partington, Sara L.
    Andrade, Lauren
    Tobin, Lynda
    Kim, Yuli
    Hoteit, Maarouf
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 637 - 637
  • [37] Risk of Liver Cirrhosis and Hepatocellular Carcinoma after Fontan Operation: A Need for Surveillance
    Yoon, Jun Sik
    Lee, Dong Ho
    Cho, Eun Ju
    Song, Mi Kyoung
    Choi, Young Hun
    Kim, Gi Beom
    Lee, Yun Bin
    Lee, Jeong-Hoon
    Yu, Su Jong
    Kim, Haeryoung
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Bae, Eun Jung
    CANCERS, 2020, 12 (07) : 1 - 12
  • [38] Pregnancy in patients with the Fontan operation
    Montanaro, Claudia
    Boyle, Siobhan
    Wander, Gurleen
    Johnson, Mark R.
    Roos-Hesselink, Jolien W.
    Patel, Roshni
    Rafiq, Isma
    Silversides, Candice K.
    Gatzoulis, Michael A.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 31 (11) : 1336 - 1344
  • [39] Hyperuricemia reflects global Fontan pathophysiology and associates with morbidity and mortality in patients after the Fontan operation
    Ohuchi, Hideo
    Negishi, Jun
    Hayama, Yosuke
    Sasaki, Osamu
    Taniguchi, Yuki
    Noritake, Kanae
    Miyazaki, Aya
    Yamada, Osamu
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 184 : 623 - 630
  • [40] Fontan-Associated Liver Disease: Evidence for Early Surveillance of Liver Health in Pediatric Fontan Patients
    Rathgeber, Steven L.
    Harris, Kevin C.
    CANADIAN JOURNAL OF CARDIOLOGY, 2019, 35 (02) : 217 - 220